4-Bromo-3,5-dimethoxyamphetamine
| Clinical data | |
|---|---|
| Other names | 4-Bromo-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-bromoamphetamine; 4,3,5-DOB; 3C-DBR; 4-Bromo-TMA; 4-Bromo-3,4,5-TMA |
| Routes of administration | Oral |
| Drug class | Serotonin receptor modulator; Psychoactive drug; Analgesic; Tactile anesthetic |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 8–12 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H16BrNO2 |
| Molar mass | 274.158 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
4-Br-3,5-DMA, also known as 4-bromo-3,5-dimethoxyamphetamine, 3C-DBR, or 4-bromo-TMA, is a psychoactive drug of the phenethylamine, amphetamine, and 3C-desoxyscaline families related to mescaline. It is the analogue of TMA in which the methoxy group at the 4 position has been replaced with a bromine atom. In addition, 4-Br-3,5-DMA is a positional isomer of DOB with the methoxy group at the 2 position located instead at the 3 position.
Category:
- Drugs not assigned an ATC code